Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Healthcare private equity firm acquires Symmetry Surgical

RoundTable Healthcare Partners, a healthcare private equity firm based in Lake Forest, Ill., has finalized a deal to acquire Symmetry Surgical, a marketer of surgical instruments and specialty devices based in Nashville.

NIH-funded study will track Zika infections on U.S. Olympic team

Athletes, coaches and staff traveling to Brazil as part of the 2016 Summer Olympics and Paralympics will be monitored by researchers for potential exposure to the Zika virus.

Thumbnail

Nonin Medical appoints new senior leadership

Nonin Medical, based in Minneapolis, made several changes to its senior leadership team as it makes plans to grow and expand.

Largest generic drug company may join PhRMA

The trade association for brand-name drug manufacturers could soon count the largest generic drug maker among its members—and the brand-name companies aren’t entirely comfortable with the idea.

Medical device company Sequana names new chairman

Switzerland-based Sequana Medical has appointed a new chairman to their board of directors as the company expands its international commercialization of its fluid pump. 

ACA co-ops face big risk-adjustment charges

Some of the smallest insurance companies will be the biggest payers into the risk adjustment program established under the Affordable Care Act for this year.

Nearly 600 U.S. clinics could be selling unregulated stem cell treatments

The risks of “stem cell tourism” might be overplayed, according to a new paper published June 30 in the journal Cell Stem Cell. But only because the real risks of unregulated stem cells might actually be within the U.S. 

1.6 million ACA exchange customers dropped out by March

Nearly 13 percent of the 12.7 million people who bought coverage on the Affordable Care Act’s health insurance marketplaces for 2016 had dropped out by the end of March.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.